Page 101 - 《中国药科大学学报》2025年第5期
P. 101

第  56 卷第  5 期       更 桑,等:基于网络药理学探究藏药佐汤卡擦丸治疗高血压的药理作用机制                                     633

               NO  水平,促进血管舒张          [13] 。血管内皮生长因子                 mune-driven theory in full effect[J]. Int J Mol Sci, 2021, 22(7):
                                                                     3451.
               (vascular endothelial growth factor,VEGF)是正常血
                                                                [3]   Gkaliagkousi  E,  Gavriilaki  E,  Triantafyllou  A,  et  al.  Clinical
               管生长所必需的,有研究指出血管内皮生长因子受                                significance of  endothelial  dysfunction  in  essential   hyperten-
               体(VEGF receptor,VEGFR)抑制剂通过减少细胞内                      sion[J]. Curr Hypertens Rep, 2015, 17(11): 85.
               受体酪氨酸激酶的激活,抑制                PI3K/AKT  信号通       [4]   Revision Committee of Chinese Guidelines for Prevention and
                                                                     Treatment of Hypertension, China Hypertension League, Soci-
               路,从而减少      eNOS  磷酸化和     NO  的释放  ;此外,              ety of Hypertension of China International Exchange and Pro-
                                                     [14]
               VEGF  通过   VEGFR  依赖性途径激活         JAK2/STAT3          motive Association for Medical and Health Care, et al. Chinese
               信号通路,从而增加细胞间黏附分子                 1(intercellular      Guidelines  for  the  Prevention  and  Treatment  of  Hypertension
                                                                     (2024 revision)[J]. Chin J Hypertens (中华高血压杂志), 2024,
               cell adhesion molecule-1,ICAM-1)的表达,参与调节              32(7): 603-700.
                                    [15]
               血管内皮屏障的完整性 。炎症、氧化应激和代谢                           [5]   Dzau VJ, Hodgkinson CP. RNA therapeutics for the cardiovas-
               改变也能通过影响         VEC  功能参与血压的调节。IL-                   cular system[J]. Circulation, 2024, 149(9): 707-716.
                                                                [6]   Guo YR. Interventional effects and preliminary mechanisms of
               6 作为重要的炎症因子,以            JAK1/2 依赖性方式增                Tibetan  medicine  Qingxue  Pill  in  spontaneously  hypertensive
               加  VEGF、eNOS   和缺氧诱导因子-1 亚基          α(hypoxia        rats  based  on  erythrocytes  (基于红细胞探讨藏药清血丸对自
               inducible factor 1 subunit α,HIF-1α)的表达,从而促           发性高血压大鼠的干预作用及初步机制研究)[D].            Xizang:
                                                                     Minzu University of China, 2021.
               进血管舒张 。此外,也有研究指出                 TNF-α  通过抑
                          [16]
                                                                [7]   Zhong GY, Song MX. Ethnic Medicine Formulations and Pre-
               制  PI3K/AKT/eNOS  通路损害     VEC  的舒张功能 。               scription  Herbs:  Varieties,  Botanical  Origins,  and  Standards
                                                         [17]
                    本研究通过网络药理学和体内实验初步探讨                              [M]. Beijing: People’s Medical Publishing House (人民卫生出
                                                                     版社), 2020: 15-20.
               了  ZTKCW   治疗高血压的作用机制。网络药理学
                                                                [8]   Yang YY, Yin LH, Zhu MN, et al. Protective effects of dioscin
               分析筛选出      ZTKCW   的多个核心成分,包括鸭嘴花                      on vascular remodeling in pulmonary arterial hypertension via
               考林酮碱、木犀草素、异紫堇球碱、秦皮乙素、甘草                               adjusting  GRB2/ERK/PI3K-AKT  signal[J].  Biomed  Pharma-
                                                                     cother, 2021, 133: 111056.
               素、鞣花酸、3-甲氧基大叶茜草素和                 crocusatins B,
                                                                [9]   Cheng Y, Shen AL, Wu XY, et al. Qingda granule attenuates
               同时筛选出多个药物-疾病关键靶点(如                     AKT1、          angiotensin  II-induced  cardiac  hypertrophy  and  apoptosis  and
               TNF、IL6、SRC、EGFR、STAT3 等),这些靶点涉及                      modulates  the  PI3K/AKT  pathway[J].  Biomed  Pharmacother,
                                                                     2021, 133: 111022.
               脂质与动脉粥样硬化、JAK/STAT              通路、糖尿病
                                                                [10]   Ding J, Yu M, Jiang JC, et al. Angiotensin II decreases endothe-
               心 肌 病 、 NF-κB  通 路 等 重 要 生 物 学 过 程 , 其 中              lial  nitric  oxide  synthase  phosphorylation  via  AT 1 R
               PIK3CA、PIK3R1、MAPK8 和      AKT1 等靶点是通路                No x /ROS/PP2A pathway[J]. Front Physiol, 2020, 11: 566410.
                                                                [11]   Marlina Manhiani M, Seth DM, Banes-Berceli AKL, et al. The
               中活跃的药物-疾病靶点。体内实验进一步证实
                                                                     role of IL-6 in the physiologic versus hypertensive blood pres-
               ZTKCW   具有降低     SHR  大鼠血压的作用,并能够减                    sure  actions  of  angiotensin  II[J].  Physiol  Rep,  2015,  3(10):
               轻心脏和胸主动脉中           PI3K/AKT  通路关键靶点的                 e12595.
                                                                [12]   Frangogiannis  NG.  Cardiac  fibrosis[J].  Cardiovasc  Res,  2021,
               磷酸化水平。在本研究中,尚且缺少对靶点的血管
                                                                     117(6): 1450-1488.
               细胞定位,明确关键作用靶点的主要作用细胞能更                           [13]   Yang P, Zhang YW, Pang JF, et al. Loss of Jak2 impairs en-
               好地了解靶点功能,探究相关机制,因此,在之后的                               dothelial  function  by  attenuating  Raf-1/MEK1/Sp-1  signaling
               研究中可以考虑使用荧光共聚焦显微镜对目标蛋                                 along  with  altered  eNOS  activities[J].  Am  J  Pathol,  2013,
                                                                     183(2): 617-625.
               白进行更精确的细胞定位。本研究对                   ZTKCW   治     [14]   Camarda  N,  Travers  R,  Yang  VK,  et  al.  VEGF receptor   in-
               疗高血压的机制进行了初步探究,还需要更多的体                                hibitor-induced hypertension: emerging mechanisms and clini-
                                                                     cal implications[J]. Curr Oncol Rep, 2022, 24(4): 463-474.
               内外实验和临床研究对相关机制进行进一步探究,
                                                                [15]   Wang L, Astone M, Alam SK, et al. Suppressing STAT3 activi-
               血管内皮功能障碍是潜在的研究方向。                                     ty protects the endothelial barrier from VEGF-mediated vascu-
                                                                     lar  permeability[J].  Dis  Model  Mech,  2021,  14(11):
                                                                     dmm049029.
               References
                                                                [16]   Subotički T, Mitrović Ajtić O, Živković E, et al. VEGF regula-
               [1]   Guarner-Lans  V,  Ramírez-Higuera  A,  Rubio-Ruiz  ME,  et  al.  tion of angiogenic factors via inflammatory signaling in myelo-
                    Early programming of adult systemic essential hypertension[J].  proliferative neoplasms[J]. Int J Mol Sci, 2021, 22(13): 6671.
                    Int J Mol Sci, 2020, 21(4): 1203.           [17]   Xiao M, Men LN, Xu MG, et al. Berberine protects endothelial
               [2]   Lazaridis A, Gavriilaki E, Douma S, et al. Toll-like receptors in  progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS
                    the pathogenesis of essential hypertension. A forthcoming im-  signaling pathway[J]. Eur J Pharmacol, 2014, 743: 11-16.
   96   97   98   99   100   101   102   103   104   105   106